Annual revenue:
$682.16M+$125.78M(+22.61%)Summary
- As of today (May 21, 2025), NVAX annual revenue is $682.16 million, with the most recent change of +$125.78 million (+22.61%) on December 31, 2024.
- During the last 3 years, NVAX annual revenue has risen by +$484.58 million (+245.26%).
- NVAX annual revenue is now -57.34% below its all-time high of $1.60 billion, reached on December 31, 2022.
Performance
NVAX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$626.33M+$538.02M(+609.24%)Summary
- As of today (May 21, 2025), NVAX quarterly revenue is $626.33 million, with the most recent change of +$538.02 million (+609.24%) on March 31, 2025.
- Over the past year, NVAX quarterly revenue has increased by +$532.48 million (+567.34%).
- NVAX quarterly revenue is now -0.31% below its all-time high of $628.30 million, reached on September 30, 2022.
Performance
NVAX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$1.21B+$532.48M(+78.06%)Summary
- As of today (May 21, 2025), NVAX TTM revenue is $1.21 billion, with the most recent change of +$532.48 million (+78.06%) on March 31, 2025.
- Over the past year, NVAX TTM revenue has increased by +$420.90 million (+53.03%).
- NVAX TTM revenue is now -28.83% below its all-time high of $1.71 billion, reached on December 31, 2022.
Performance
NVAX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVAX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.6% | +567.3% | +53.0% |
| 3 y3 years | +245.3% | +3.6% | +242.1% |
| 5 y5 years | +3555.3% | +10000.0% | +6626.7% |
NVAX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.3% | +245.3% | -0.3% | +9843.8% | -28.8% | +400.0% |
| 5 y | 5-year | -57.3% | +3555.3% | -0.3% | +186.2% | -28.8% | +6626.7% |
| alltime | all time | -57.3% | >+9999.0% | -0.3% | +186.2% | -28.8% | >+9999.0% |
NVAX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $626.33M(+609.2%) | $1.21B(+78.1%) |
| Dec 2024 | $682.16M(+22.6%) | $88.31M(+4.5%) | $682.16M(-19.5%) |
| Sep 2024 | - | $84.51M(-79.7%) | $847.25M(+8.0%) |
| Jun 2024 | - | $415.48M(+342.7%) | $784.80M(-1.1%) |
| Mar 2024 | - | $93.86M(-63.0%) | $793.74M(+14.5%) |
| Dec 2023 | $556.38M(-65.2%) | $253.40M(+1048.5%) | $693.46M(-4.7%) |
| Sep 2023 | - | $22.06M(-94.8%) | $727.89M(-45.4%) |
| Jun 2023 | - | $424.43M(-6702.8%) | $1.33B(+21.8%) |
| Mar 2023 | - | -$6.43M(-102.2%) | $1.10B(-35.8%) |
| Dec 2022 | $1.60B(+709.3%) | $287.83M(-54.2%) | $1.71B(+146.5%) |
| Sep 2022 | - | $628.30M(+237.9%) | $692.39M(+185.0%) |
| Jun 2022 | - | $185.93M(-69.3%) | $242.93M(-31.6%) |
| Mar 2022 | - | $604.67M(-183.2%) | $355.02M(+79.7%) |
| Dec 2021 | $197.58M(+782.5%) | -$726.51M(-506.2%) | $197.58M(-73.7%) |
| Sep 2021 | - | $178.84M(-40.0%) | $750.54M(+3.0%) |
| Jun 2021 | - | $298.02M(-33.4%) | $728.72M(+56.3%) |
| Mar 2021 | - | $447.23M(-357.7%) | $466.24M(+1982.5%) |
| Dec 2020 | $22.39M(+20.0%) | -$173.55M(-210.5%) | $22.39M(-89.1%) |
| Sep 2020 | - | $157.02M(+341.8%) | $204.75M(+307.6%) |
| Jun 2020 | - | $35.54M(+952.4%) | $50.24M(+178.2%) |
| Mar 2020 | - | $3.38M(-61.7%) | $18.06M(-3.2%) |
| Dec 2019 | $18.66M(-45.6%) | $8.82M(+251.7%) | $18.66M(+16.8%) |
| Sep 2019 | - | $2.51M(-25.3%) | $15.97M(-24.7%) |
| Jun 2019 | - | $3.36M(-15.7%) | $21.20M(-25.9%) |
| Mar 2019 | - | $3.98M(-35.0%) | $28.62M(-16.5%) |
| Dec 2018 | $34.29M(+10.0%) | $6.13M(-20.8%) | $34.29M(-11.1%) |
| Sep 2018 | - | $7.74M(-28.2%) | $38.57M(-1.6%) |
| Jun 2018 | - | $10.77M(+11.6%) | $39.19M(+11.5%) |
| Mar 2018 | - | $9.65M(-7.3%) | $35.15M(+12.7%) |
| Dec 2017 | $31.18M(+103.1%) | $10.41M(+24.7%) | $31.18M(+19.2%) |
| Sep 2017 | - | $8.35M(+24.1%) | $26.16M(+24.3%) |
| Jun 2017 | - | $6.73M(+18.5%) | $21.04M(+25.1%) |
| Mar 2017 | - | $5.68M(+5.2%) | $16.82M(+9.5%) |
| Dec 2016 | $15.35M(-57.6%) | $5.40M(+67.1%) | $15.35M(-2.9%) |
| Sep 2016 | - | $3.23M(+29.0%) | $15.81M(-17.2%) |
| Jun 2016 | - | $2.50M(-40.6%) | $19.10M(-37.6%) |
| Mar 2016 | - | $4.22M(-27.9%) | $30.59M(-15.6%) |
| Dec 2015 | $36.25M(+18.2%) | $5.85M(-10.3%) | $36.25M(-2.3%) |
| Sep 2015 | - | $6.53M(-53.4%) | $37.12M(-4.4%) |
| Jun 2015 | - | $14.00M(+41.7%) | $38.81M(+17.3%) |
| Mar 2015 | - | $9.88M(+46.9%) | $33.07M(+7.9%) |
| Dec 2014 | $30.66M(+46.6%) | $6.72M(-18.1%) | $30.66M(-6.2%) |
| Sep 2014 | - | $8.21M(-0.5%) | $32.68M(+11.7%) |
| Jun 2014 | - | $8.26M(+10.7%) | $29.27M(+19.3%) |
| Mar 2014 | - | $7.46M(-14.7%) | $24.54M(+17.4%) |
| Dec 2013 | $20.91M(-5.3%) | $8.75M(+82.2%) | $20.91M(+25.0%) |
| Sep 2013 | - | $4.80M(+36.0%) | $16.73M(-5.4%) |
| Jun 2013 | - | $3.53M(-7.9%) | $17.70M(-16.8%) |
| Mar 2013 | - | $3.83M(-16.1%) | $21.27M(-3.7%) |
| Dec 2012 | $22.08M(+50.3%) | $4.57M(-20.8%) | $22.08M(-5.5%) |
| Sep 2012 | - | $5.76M(-18.8%) | $23.36M(+3.3%) |
| Jun 2012 | - | $7.10M(+53.0%) | $22.60M(+22.2%) |
| Mar 2012 | - | $4.64M(-20.6%) | $18.50M(+25.9%) |
| Dec 2011 | $14.69M(+4182.2%) | $5.84M(+16.7%) | $14.69M(+65.1%) |
| Sep 2011 | - | $5.01M(+66.9%) | $8.89M(+119.0%) |
| Jun 2011 | - | $3.00M(+259.8%) | $4.06M(+280.6%) |
| Mar 2011 | - | $834.00K(+1535.3%) | $1.07M(+211.1%) |
| Dec 2010 | $343.00K | $51.00K(-70.9%) | $343.00K(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $175.00K(+2400.0%) | $366.00K(-6.6%) |
| Jun 2010 | - | $7000.00(-93.6%) | $392.00K(-5.3%) |
| Mar 2010 | - | $110.00K(+48.6%) | $414.00K(+27.4%) |
| Dec 2009 | $325.00K(-69.5%) | $74.00K(-63.2%) | $325.00K(+1.2%) |
| Sep 2009 | - | $201.00K(+593.1%) | $321.00K(+2.2%) |
| Jun 2009 | - | $29.00K(+38.1%) | $314.00K(-49.9%) |
| Mar 2009 | - | $21.00K(-70.0%) | $627.00K(-41.1%) |
| Dec 2008 | $1.06M(-29.7%) | $70.00K(-63.9%) | $1.06M(+191.5%) |
| Sep 2008 | - | $194.00K(-43.3%) | $365.00K(-75.4%) |
| Jun 2008 | - | $342.00K(-25.3%) | $1.49M(+14.1%) |
| Mar 2008 | - | $458.00K(-172.8%) | $1.30M(-0.2%) |
| Dec 2007 | $1.51M(-12.9%) | -$629.00K(-147.8%) | $1.30M(+287.2%) |
| Sep 2007 | - | $1.31M(+732.3%) | $337.00K(+56.7%) |
| Jun 2007 | - | $158.00K(-65.7%) | $215.00K(-76.0%) |
| Mar 2007 | - | $461.00K(-128.9%) | $896.00K(-48.4%) |
| Dec 2006 | $1.74M(-67.5%) | -$1.60M(-233.9%) | $1.74M(-50.8%) |
| Sep 2006 | - | $1.19M(+42.2%) | $3.53M(-16.0%) |
| Jun 2006 | - | $839.00K(-35.6%) | $4.21M(-26.0%) |
| Mar 2006 | - | $1.30M(+554.8%) | $5.68M(+6.4%) |
| Dec 2005 | $5.34M(-35.3%) | $199.00K(-89.3%) | $5.34M(-25.7%) |
| Sep 2005 | - | $1.87M(-19.4%) | $7.19M(+20.3%) |
| Jun 2005 | - | $2.31M(+140.6%) | $5.98M(-10.4%) |
| Mar 2005 | - | $962.00K(-53.0%) | $6.67M(-25.3%) |
| Dec 2004 | $8.26M(-29.9%) | $2.05M(+213.3%) | $8.92M(-18.3%) |
| Sep 2004 | - | $653.00K(-78.3%) | $10.93M(-24.9%) |
| Jun 2004 | - | $3.00M(-6.7%) | $14.54M(+5.3%) |
| Mar 2004 | - | $3.22M(-20.5%) | $13.81M(+17.2%) |
| Dec 2003 | $11.79M(-21.5%) | $4.05M(-5.2%) | $11.79M(+15.1%) |
| Sep 2003 | - | $4.27M(+87.6%) | $10.24M(+23.4%) |
| Jun 2003 | - | $2.27M(+90.5%) | $8.30M(-20.9%) |
| Mar 2003 | - | $1.19M(-52.2%) | $10.48M(-30.1%) |
| Dec 2002 | $15.01M(-37.7%) | $2.50M(+7.3%) | $15.00M(-19.4%) |
| Sep 2002 | - | $2.33M(-47.8%) | $18.62M(-12.7%) |
| Jun 2002 | - | $4.46M(-21.9%) | $21.33M(-14.0%) |
| Mar 2002 | - | $5.71M(-6.6%) | $24.81M(+3.1%) |
| Dec 2001 | $24.07M(+872.4%) | $6.12M(+21.4%) | $24.07M(+28.3%) |
| Sep 2001 | - | $5.04M(-36.6%) | $18.76M(+33.1%) |
| Jun 2001 | - | $7.95M(+60.0%) | $14.09M(+109.3%) |
| Mar 2001 | - | $4.97M(+515.4%) | $6.73M(+172.0%) |
| Dec 2000 | $2.48M(+106.3%) | $807.00K(+118.1%) | $2.48M(+4.5%) |
| Sep 2000 | - | $370.00K(-37.1%) | $2.37M(+12.9%) |
| Jun 2000 | - | $588.00K(-17.2%) | $2.10M(+15.9%) |
| Mar 2000 | - | $710.00K(+1.4%) | $1.81M(+50.8%) |
| Dec 1999 | $1.20M(+71.4%) | $700.00K(+600.0%) | $1.20M(+71.4%) |
| Sep 1999 | - | $100.00K(-66.7%) | $700.00K(-12.5%) |
| Jun 1999 | - | $300.00K(+200.0%) | $800.00K(+33.3%) |
| Mar 1999 | - | $100.00K(-50.0%) | $600.00K(-14.3%) |
| Dec 1998 | $700.00K(+40.0%) | $200.00K(0.0%) | $700.00K(-12.5%) |
| Sep 1998 | - | $200.00K(+100.0%) | $800.00K(+14.3%) |
| Jun 1998 | - | $100.00K(-50.0%) | $700.00K(0.0%) |
| Mar 1998 | - | $200.00K(-33.3%) | $700.00K(+16.7%) |
| Dec 1997 | $500.00K(+400.0%) | $300.00K(+200.0%) | $600.00K(+100.0%) |
| Sep 1997 | - | $100.00K(0.0%) | $300.00K(0.0%) |
| Jun 1997 | - | $100.00K(0.0%) | $300.00K(0.0%) |
| Mar 1997 | - | $100.00K(0.0%) | $300.00K(0.0%) |
| Dec 1996 | $100.00K | - | - |
| Sep 1996 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Jun 1996 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is Novavax annual revenue?
- What is the all time high annual revenue for Novavax?
- What is Novavax annual revenue year-on-year change?
- What is Novavax quarterly revenue?
- What is the all time high quarterly revenue for Novavax?
- What is Novavax quarterly revenue year-on-year change?
- What is Novavax TTM revenue?
- What is the all time high TTM revenue for Novavax?
- What is Novavax TTM revenue year-on-year change?
What is Novavax annual revenue?
The current annual revenue of NVAX is $682.16M
What is the all time high annual revenue for Novavax?
Novavax all-time high annual revenue is $1.60B
What is Novavax annual revenue year-on-year change?
Over the past year, NVAX annual revenue has changed by +$125.78M (+22.61%)
What is Novavax quarterly revenue?
The current quarterly revenue of NVAX is $626.33M
What is the all time high quarterly revenue for Novavax?
Novavax all-time high quarterly revenue is $628.30M
What is Novavax quarterly revenue year-on-year change?
Over the past year, NVAX quarterly revenue has changed by +$532.48M (+567.34%)
What is Novavax TTM revenue?
The current TTM revenue of NVAX is $1.21B
What is the all time high TTM revenue for Novavax?
Novavax all-time high TTM revenue is $1.71B
What is Novavax TTM revenue year-on-year change?
Over the past year, NVAX TTM revenue has changed by +$420.90M (+53.03%)